Re-assessment of aPLs revealed a persistent high titer of aβ2GPI IgA (>400 U/ml, normal range 0–20 U/ml) with negative consensus aPLs, confirming the diagnosis of non-criteria APS and ischemic stroke secondary to the rare etiology. Here, CD79A is linked to ischemic stroke.